BusinessIHMA Completes the Globalization of its Two Laboratories with the Recent College of American Pathologists (CAP) Accreditation of IHMA Europe, Enhancing Support for Clinical Trials in Anti-Infective Drug Development and Global Surveillance StudiesBy Nasdaq OMXMar 6, 2018, 10:20 PM UTC
BusinessNTS Ventures and IHMA Announce a Collaborative Agreement to Provide an Extensive Suite of Clinical Mycology, Antifungal and Microbiology Laboratory Services to Support Anti-infective Drug Development to the Biopharmaceutical IndustryBy Nasdaq OMXDec 4, 2017, 10:24 PM UTC
BusinessRapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for VaccinesBy Nasdaq OMXOct 23, 2017, 11:00 AM UTC
BusinessAccelerate Diagnostics Schedules Call to Review Third Quarter 2017 Results for November 2ndBy Nasdaq OMXOct 16, 2017, 5:59 PM UTC
BusinessAccelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating PlacementsBy Nasdaq OMXAug 3, 2017, 8:00 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
BusinessAccelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017By Nasdaq OMXMay 3, 2017, 8:08 PM UTC
